These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18833701)

  • 1. [Pathophysiology of paraneoplastic neurological syndromes: role of cellular immunity].
    Tanaka M
    Nihon Naika Gakkai Zasshi; 2008 Aug; 97(8):1816-22. PubMed ID: 18833701
    [No Abstract]   [Full Text] [Related]  

  • 2. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
    Bradwell AR
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychiatric manifestations of paraneoplastic disorders.
    Kayser MS; Kohler CG; Dalmau J
    Am J Psychiatry; 2010 Sep; 167(9):1039-50. PubMed ID: 20439389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoantibodies in Paraneoplastic Neurological Syndrome].
    Kawachi I
    Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic tests: Anti-Purkinje cell antibody (Anti-Yo/type 1 antibody)].
    Tanaka K
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():479-82. PubMed ID: 16111307
    [No Abstract]   [Full Text] [Related]  

  • 6. [Paraneoplastic neurological syndromes and autoimmune encephalitis].
    Stich O; Rauer S
    Nervenarzt; 2014 Apr; 85(4):485-98; quiz 499-501. PubMed ID: 24668402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunopathogenesis of paraneoplastic neurological syndromes.
    Sutton I; Winer JB
    Clin Sci (Lond); 2002 May; 102(5):475-86. PubMed ID: 11980564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism of paraneoplastic neurological syndrome].
    Inuzuka T
    Nihon Ronen Igakkai Zasshi; 2003 May; 40(3):204-9. PubMed ID: 12822462
    [No Abstract]   [Full Text] [Related]  

  • 9. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes.
    Shams'ili S; de Beukelaar J; Gratama JW; Hooijkaas H; van den Bent M; van 't Veer M; Sillevis Smitt P
    J Neurol; 2006 Jan; 253(1):16-20. PubMed ID: 16444604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of paraneoplastic neurological syndromes].
    Tanaka K
    Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity.
    Darnell RB
    Arch Neurol; 2004 Jan; 61(1):30-2. PubMed ID: 14732616
    [No Abstract]   [Full Text] [Related]  

  • 13. Hu, Yo, Ri, Ma, Ta: monosyllabic answers to complex questions.
    Verschuuren J
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):742. PubMed ID: 18559456
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sudden death occurring after anti-Hu associated paraneoplastic cerebellar degeneration and dysautonomia revealing a small cell lung carcinoma].
    Mirouse A; Gobert D; Chamouard JM; Iordache L; Mekinian A; Fain O
    Rev Med Interne; 2014 Nov; 35(11):757-9. PubMed ID: 24411475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic neurological syndromes.
    Sutton I
    Curr Opin Neurol; 2002 Dec; 15(6):685-90. PubMed ID: 12447106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic anti-HU syndrome associated with uterine tumor.
    Côté-Mantha E; Savard M
    Can J Neurol Sci; 2012 Mar; 39(2):254-5. PubMed ID: 22506291
    [No Abstract]   [Full Text] [Related]  

  • 17. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advance in immunological tests in paraneoplastic neurological syndrome.
    Fong CS
    Acta Neurol Taiwan; 2005 Mar; 14(1):28-35. PubMed ID: 15835287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic gaze palsies in a patient with negative anti-Hu and anti-Yo antibody tests.
    Okun MS; Bhatti MT; Eskin T; Eisenschenk S; Watson RT
    South Med J; 2002 Dec; 95(12):1459. PubMed ID: 12597321
    [No Abstract]   [Full Text] [Related]  

  • 20. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
    Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
    J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.